FDA Should Remove Diabetes Drug Victoza From Market, Public Citizen Says

The Food and Drug Administration should immediately remove from the market the diabetes drug Victoza (liraglutide) because it puts patients at higher risk of thyroid cancer, pancreatitis, serious allergic reactions, and kidney failure, consumer group Public Citizen said in a citizen petition sent April 19 to the agency.

Victoza, which is made by Novo Nordisk, was approved in January 2010 (8 PLIR 141, 1/29/10), against the advice of two reviewing FDA pharmacologists and an FDA clinical safety reviewer, Public Citizen said. By June 2011, FDA had issued new warnings linking the drug to pancreatitis, thyroid cancer, and renal ...